Showing results (711-720 of 1,465) with videos related to
Sort By:
Pageof 147
British Journal of Cancer|April 7, 2005
Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cellsD J A de Groot, T Timmer, D C J Spierings, et al.Gynecologic Oncology|December 17, 2003
Pilot study of vaginal plethysmography in women treated with radiotherapy for gynecological cancerElisabeth Pras, Jan Wouda, Pax H B Willemse, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1987
B cell growth-promoting activity of recombinant human interleukin 4T Defrance, B Vanbervliet, J P Aubry, et al.Current Drug Targets|July 23, 2011
Targeting TRAIL towards the clinicDevalingam Mahalingam, Corina N A M Oldenhuis, Eva Szegezdi, et al.Psychosomatic Medicine|June 9, 2004
Patients with carcinoid syndrome exhibit symptoms of aggressive impulse dysregulationSascha Russo, Jim C Boon, Ido P Kema, et al.Critical Reviews in Oncology/Hematology|February 28, 2018
Evolution in sentinel lymph node biopsy in breast cancerSi-Qi Qiu, Guo-Jun Zhang, Liesbeth Jansen, et al.European Journal of Cancer (Oxford, England : 1990)|August 15, 2013
β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort studyE Livingstone, L M Hollestein, M P P van Herk-Sukel, et al.Psycho-Oncology|April 11, 2026
Managing Cancer and Living Meaningfully (CALM) for Patients With Metastatic Cancer and Treatment ResponseFroukje E de Vries, Emma Hafkamp, Anne Huisman, et al.The British Journal of Dermatology|August 14, 2012
Basal cell carcinomas without histological confirmation and their treatment: an audit in four European regionsS C Flohil, C M Proby, A D Forrest, et al.Journal of Neuroinflammation|February 13, 2024
The role of CD56bright NK cells in neurodegenerative disordersCarla Rodriguez-Mogeda, Chaja M J van Ansenwoude, Lennart van der Molen, et al.Pageof 147